Team:HIT-Harbin/Safety

From 2014.igem.org

(Difference between revisions)
Line 109: Line 109:
     </div>
     </div>
   </div>
   </div>
 +
 +
<!--content-->
 +
 +
<div id="content">   
 +
            <div id="subheader-bar">
 +
                    <div class="site-description"><h4><span class="colored"><cufon class="cufon cufon-canvas" alt="Safety" style="width: 65px; height: 20px;"><canvas width="71" height="27" style="width: 71px; height: 27px; top: -7px; left: 1px;"></canvas><cufontext>Safety</cufontext></cufon></span></h4></div>
 +
                   
 +
           
 +
                <div class="mainarea">
 +
                    <div class="multi-columns">
 +
                        <div class="half">
 +
                            <p></p>1.Risks to the safety and health of team members or others working in the lab?
 +
<p>No risk. All that we use in our lab are harmless to workers under normal conditions. Once we finished our experiment, all wares we used would be sterilized in high temperature, then we would discard waste in waste bins designated for our iGEM lab, and we would wear gloves when we washed wares.</p>
 +
                        </div>
 +
                        <div class="half last">
 +
                            <p></p>2.Risks to the safety and health of the general public, if released by design or by accident?
 +
<p>No risk. Our biological materials cannot prevail in natural environment because of their special requirements of cultivation and competitions between microorganisms.
 +
</p>
 +
                        </div>
 +
                    </div>
 +
 +
                    <div class="multi-columns">
 +
                        <div class="third">
 +
                            <p></p>3.Risks to the environment, if released by design or by accident?
 +
<p>No risk. Our biological materials cannot prevail in natural environment because of their special requirements of cultivation and competitions between microorganisms.
 +
</p>
 +
                        </div>
 +
                        <div class="third">
 +
                            <p></p>4.Risks to security through malicious misuse by individuals, groups, or countries?
 +
<p>No risk. Our biological materials have no latent menace more than general biological materials.</p>
 +
                        </div>
 +
                        <div class="third last">
 +
                            <p></p>5.If your project moved from a small-scale lab study to become widely used as a commercial/industrial product, what new risks might arise? Also, what risks might arise if the knowledge you generate or the methods you develop became widely available?
 +
<p>No risk. Our project is friendly to public and environment.</p>
 +
                        </div>
 +
                    </div>
 +
 +
                    <div class="multi-columns">
 +
                        <div class="fourth">
 +
                            <p></p>6.Does your project include any design features to address safety risks? (For example: kill switches, auxotrophic chassis, etc.) Note that including such features is not mandatory to participate in iGEM, but many groups choose to include them.
 +
<p>No, because simple processes, such as sterilizing, can solve the safety problems. Even if we do nothing, the bacteria we use will die due to lack of nutrition, before they propagate.</p>
 +
                        </div>
 +
                        <div class="fourth">
 +
                            <p></p>7.What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.
 +
<p>We received safety training about the self-protection, experimental rules, and methods under emergent conditions.
 +
</p>
 +
                        </div>
 +
                        <div class="fourth">
 +
                            <p></p>8.Does your institution have an Institutional Biosafety Committee, or an equivalent group? If yes, have you discussed your project with them? Describe any concerns they raised with your project, and any changes you made to your project plan based on their review.
 +
<p>Yes, our institution has the committee that establish guidelines and policies on biosafety. Evaluation of biosafety are regularly carried out, including evaluation of research proposals and monitoring of experimental procedures.
 +
</p>
 +
                        </div>
 +
 +
                        <div class="fourth last">
 +
                            <p></p>9.Does your country have national biosafety regulations or guidelines? If so, please provide a link to these regulations or guidelines if possible.
 +
<p>http://english.biosafety.gov.cn/
 +
</p>
 +
                        </div>
 +
                    </div>                     
 +
 +
</div>
 +
</div>
 +
 +
       
 +
 +
 +
<p></p>
 +
<!--
 +
NewPP limit report
 +
Preprocessor node count: 14/1000000
 +
Post-expand include size: 82/2097152 bytes
 +
Template argument size: 0/2097152 bytes
 +
Expensive parser function count: 0/100
 +
-->
 +
 +
<!-- Saved in parser cache with key 2013_igem_org:pcache:idhash:1769-0!1!0!!en!2 and timestamp 20140816124200 -->
 +
<div class="printfooter">
 +
Retrieved from "<a href="https://2013.igem.org/Team:HIT-Harbin/Safety">https://2013.igem.org/Team:HIT-Harbin/Safety</a>"</div>
 +
<div id="catlinks"><div id="catlinks" class="catlinks catlinks-allhidden"></div></div> <!-- end content -->
 +
<div class="visualClear"></div>
 +
</div>
 +
</div>
</div>
<script>toolbar('nav')</script>
<script>toolbar('nav')</script>

Revision as of 12:42, 16 August 2014

Project
  • Abstract
  • Background
  • Design
  • Modeling
  • Results
  • Future Work
Judging
  • Biobrick
  • Achievement
Wetlab
  • Protocols
  • Notebook
Team
  • Members
  • Advisors
  • Instructors
  • Attribution
  • Acknowledge
Human  practic
  • Country Profile
  • Qualification Trials
  • Wechat Platform
  • Video
  • Presentation

Safety

1.Risks to the safety and health of team members or others working in the lab?

No risk. All that we use in our lab are harmless to workers under normal conditions. Once we finished our experiment, all wares we used would be sterilized in high temperature, then we would discard waste in waste bins designated for our iGEM lab, and we would wear gloves when we washed wares.

2.Risks to the safety and health of the general public, if released by design or by accident?

No risk. Our biological materials cannot prevail in natural environment because of their special requirements of cultivation and competitions between microorganisms.

3.Risks to the environment, if released by design or by accident?

No risk. Our biological materials cannot prevail in natural environment because of their special requirements of cultivation and competitions between microorganisms.

4.Risks to security through malicious misuse by individuals, groups, or countries?

No risk. Our biological materials have no latent menace more than general biological materials.

5.If your project moved from a small-scale lab study to become widely used as a commercial/industrial product, what new risks might arise? Also, what risks might arise if the knowledge you generate or the methods you develop became widely available?

No risk. Our project is friendly to public and environment.

6.Does your project include any design features to address safety risks? (For example: kill switches, auxotrophic chassis, etc.) Note that including such features is not mandatory to participate in iGEM, but many groups choose to include them.

No, because simple processes, such as sterilizing, can solve the safety problems. Even if we do nothing, the bacteria we use will die due to lack of nutrition, before they propagate.

7.What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.

We received safety training about the self-protection, experimental rules, and methods under emergent conditions.

8.Does your institution have an Institutional Biosafety Committee, or an equivalent group? If yes, have you discussed your project with them? Describe any concerns they raised with your project, and any changes you made to your project plan based on their review.

Yes, our institution has the committee that establish guidelines and policies on biosafety. Evaluation of biosafety are regularly carried out, including evaluation of research proposals and monitoring of experimental procedures.

9.Does your country have national biosafety regulations or guidelines? If so, please provide a link to these regulations or guidelines if possible.

http://english.biosafety.gov.cn/

Retrieved from "https://2013.igem.org/Team:HIT-Harbin/Safety"

Retrieved from "http://2014.igem.org/Team:HIT-Harbin/Safety"